Información:
Error:
ID
13206
Descripción
Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00005780
Link
https://clinicaltrials.gov/show/NCT00005780
Palabras clave
Versiones (1)
- 24/1/16 24/1/16 -
Subido en
24 de enero de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Mantle Cell Lymphoma NCT00005780
Eligibility Mantle Cell Lymphoma NCT00005780
- StudyEvent: Eligibility
Similar models
Eligibility Mantle Cell Lymphoma NCT00005780
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
mantle cell lymphoma
Item
tissue diagnosis of mantle cell lymphoma (confirmed in laboratory of pathology). blastic cell variant will be eligible.
boolean
C0030664 (UMLS CUI [1,1])
C0334634 (UMLS CUI [1,2])
C0334634 (UMLS CUI [1,2])
age
Item
age greater than or equal to 18.
boolean
C0001779 (UMLS CUI [1])
chemotherapy
Item
previously untreated with cytotoxic chemotherapy. patients may have received local radiation or a short course of steroids for control of symptoms.
boolean
C0392920 (UMLS CUI [1])
disease stage
Item
all stages of disease.
boolean
C0699749 (UMLS CUI [1])
lymph nodes, circulating tumor cells
Item
lymph node of greater than or equal to 2 cm accessible for biopsy/harvest or greater than 1000/microliters of circulating tumor cells in the blood.
boolean
C0024204 (UMLS CUI [1])
C3272887 (UMLS CUI [2])
C3272887 (UMLS CUI [2])
ecog
Item
ecog performance status of less than or equal to 3.
boolean
C1520224 (UMLS CUI [1])
organ function
Item
adequate major organ function (serum creatinine 1.5 mg/dl or creatinine clearance greater than 60 ml/min; bilirubin less than 2 mg/dl (total) except less than 5 mg/dl in patients with gilbert's syndrome as defined by greater than 80% unconjugated; anc greater than 1000 and platelets greater than 100,000) unless impairment due to organ involvement by lymphoma.
boolean
C0201976 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
C0948762 (UMLS CUI [4])
C0032181 (UMLS CUI [5])
C0373595 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
C0948762 (UMLS CUI [4])
C0032181 (UMLS CUI [5])
cardiac disease
Item
no active symptomatic ischemic heart disease, myocardial infarction or congestive heart failure within the past year. if muga is obtained, the lvef should exceed 40%.
boolean
C0018799 (UMLS CUI [1])
informed consent
Item
ability to give informed consent.
boolean
C0021430 (UMLS CUI [1])
hiv, hepatitis b
Item
antibodies to hiv or presence of hepatitis b surface antigen.
boolean
C0019683 (UMLS CUI [1])
C0019168 (UMLS CUI [2])
C0019168 (UMLS CUI [2])
pregnant or lactating
Item
pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
malignancy
Item
prior malignancy in past 5 years except squamous or basal cell carcinoma or curatively treated in situ of the cervix.
boolean
C0006826 (UMLS CUI [1])
cns involvement
Item
involvement of central nervous system by lymphoma.
boolean
C0449389 (UMLS CUI [1])